HART Hub funding – to establish a Homelessness and Addiction Recovery Treatment hub in Sault Ste. Marie — is vital to help ...

People should be wary of companies that don't require a prescription and offer deep discounts, the agency said. The warning comes several days after the Justice Department sued illegal online ...

A new study published in Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural ...

Trial results suggested the antibody-drug conjugate may be a treatment option for patients with HER2 metastatic breast cancer ...

The epilepsy medication sodium valproate is linked to developmental problems in fetuses, but lab studies may now have found a ...

Aldeyra Therapeutics has once again filed for Food and Drug Administration of its proposed reproxalap drug candidate for the treatment of signs and symptoms of dry-eye disease.

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to ...

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, which is growing market ...

Recent pre-clinical studies in mice show that glucagon blockers can improve heart function in HFpEF, a type of heart failure.

The FDA approved a new strength of a trastuzumab biosimilar; UnitedHealth will remove reference adalimumab from some ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...